Skip to Content

7260 93 (Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg)

Pill with imprint 7260 93 is Yellow, Elliptical / Oval and has been identified as Glyburide and Metformin Hydrochloride 1.25 mg / 250 mg. It is supplied by Teva Pharmaceuticals USA.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 1.25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 7260 93

Glyburide and Metformin Hydrochloride

Imprint
7260 93
Strength
1.25 mg / 250 mg
Color
Yellow
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7260

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.